Domain A — Pharmacology
Pharmacological key concepts bearing directly on the isomorphism:
- Agonist: A drug that activates its receptor to produce a response. Binding the receptor is necessary but not sufficient — the agonist must also cause a conformational change that triggers downstream signaling.
- Competitive antagonist: A molecule that binds the same receptor site as the agonist but does not activate it. At any given receptor, agonist and antagonist compete for occupancy. Higher antagonist concentration shifts the dose-response curve rightward — requiring more agonist for the same effect.
- Therapeutic window: The range of concentrations between the minimum effective dose and the toxic dose. Below the window: no effect. Within: desired response. Above: toxicity.
- Tolerance: Repeated exposure to an agonist at a fixed concentration produces diminishing response over time — EC50 increases, or E_max decreases — as the system downregulates receptors or adapts.
- Cooperativity (n > 1): When multiple binding events are positively coupled — binding of one agonist increases the affinity of the next — the Hill coefficient exceeds 1. The dose-response curve steepens into a near-switch. Classic example: hemoglobin oxygen binding (n ≈ 2.8).
As the Hill coefficient n approaches infinity, the sigmoidal curve degenerates into a perfect step function: zero effect below EC50, full E_max above. The Hill equation becomes a binary switch. This is the pharmacological limit corresponding to the eigenvalue structure of ISO-012 — see Section 4.
Domain B — Soteriology
The soteriological structure, mapped pharmacologically:
- Grace as agonist: Grace is the active agent — the divine initiative that produces the sanctifying effect. Like a pharmacological agonist, grace produces its effect by binding a receptor (faith), not by direct action on the system. Grace without faith produces no effect — an unbound agonist cannot activate a receptor.
- Faith as receptor: Faith is the specific binding mechanism that activates the grace effect. Faith without grace has nothing to bind — an empty receptor produces no signal. The receptor receives but does not generate the effect.
- Sin as competitive antagonist: Sin occupies the same binding site — the human will and attention — that faith occupies. Like a competitive antagonist, sin does not produce the grace-effect but blocks grace from producing it. More sin requires more grace for the same sanctifying effect (rightward shift).
- Community as cooperativity: "Where two or three are gathered in my name, there am I among them" (Matthew 18:20). This is not merely encouragement — it is a cooperativity statement. Community binding amplifies individual faith-response, steepening the dose-response curve. n > 1 = community amplification.
- E_max as maximum sanctification: "Until we all attain to the unity of the faith and of the knowledge of the Son of God, to mature manhood, to the measure of the stature of the fullness of Christ" (Ephesians 4:13). E_max is the asymptotic limit — glorification — approached but not reached in this life.
The idempotent, once-for-all mapping in this isomorphism reflects Reformed (Protestant) soteriology specifically. Catholic sacramental theology models grace as continuous — dispensed repeatedly through sacraments over a lifetime — not as a one-shot agonist application. A Catholic formalization would use a different pharmacokinetic model: perhaps a maintenance-dose regimen rather than a single binding event. This is not a flaw but a scope limitation: the Hill equation mapping encodes Reformed soteriology.
Structural Mapping
| # | Pharmacology (Domain A) | Soteriology (Domain B) | Notes |
|---|---|---|---|
| 01 | Agonist (drug that activates receptor) | Grace — the active divine agent | Produces the effect by binding the receptor; cannot act without it |
| 02 | Receptor / binding site | Faith — the receiving mechanism | Specificity: only the right agonist activates the right receptor |
| 03 | Competitive antagonist — same binding site, no activation | Sin — occupies the will/attention, blocks grace | Rightward shift: more sin → more grace required for same effect |
| 04 | EC50 — concentration for 50% of E_max | Threshold of belief — the faith tipping point | Below EC50: grace accumulates without visible effect. At EC50: half-maximal sanctification. |
| 05 | E_max — maximum possible effect | Maximum sanctification — glorification (Eph 4:13) | Asymptotic ceiling; approached through sanctification, reached only at glorification |
| 06 | Hill coefficient n — cooperativity | Community faith density — "where two or three are gathered" (Matt 18:20) | n > 1 = community amplifies individual faith response; steeper, more decisive transition |
| 07 | Tolerance — diminished response to chronic exposure | Spiritual complacency — dulled sensitivity to grace (→ ISO-026) | Receptor downregulation = EC50 increase; requires renewed repentance to restore sensitivity |
| 08 | Therapeutic window — between minimum effective and toxic dose | Balanced Christian life — neither insufficient engagement nor destructive zeal | "Zeal without knowledge" (Rom 10:2) = above-window overdose: correct goal, toxic dosing |
| 09 | Side effects — secondary, unintended effects of the active agent | Suffering in sanctification — growth produces pain (Heb 12:11) | Not evidence of wrong treatment — expected consequence of the correct agent at therapeutic dose |
| 10 | Drug interactions — multiple agents at same receptor produce complex dynamics | Competing worldviews — partial truths that mix with grace at the receptor of faith | Partial agonist worldviews may produce sub-maximal response even at high concentration |
| 11 | Pharmacokinetics — absorption, distribution, metabolism, excretion | Grace distribution — preaching, sacraments, prayer, community | How the agonist reaches the receptor; bioavailability determines effective [D] at binding site |
Connection to ISO-012: Sign Operator as Limiting Case
ISO-012 shows that moral orientation is a binary eigenstate — eigenvalues ±1 under a Hermitian operator σ. Self-generated evolution ([σ, U] = 0) cannot change the eigenvalue. This appears structurally distinct from the Hill equation's continuous sigmoidal response.
But they are the same structure at different limits. As the Hill coefficient n → ∞, the sigmoidal Hill curve degenerates into a perfect step function:
The Sign Operator σ = {−1, 0, +1} is exactly this discontinuous limit applied to moral orientation. The Hill equation is the smooth generalization of the Sign Operator — pharmacological continuity degenerates to eigenvalue discreteness at infinite cooperativity.
Theological implication: the Reformed doctrine of total depravity (moral orientation is binary, cannot be improved by self-effort) is the n → ∞ limiting case of the pharmacological grace model. Arminian models with partial moral self-improvement correspond to finite n, where the transition region has measurable width.
Romans 5:20 as Dose-Response Statement
Pharmacology predicts a specific, quantitative consequence of competitive antagonism: as the antagonist (sin) concentration increases, the dose-response curve shifts rightward. More agonist (grace) is required for the same effect. The relationship is proportional — double the competitive antagonist, double the agonist required for identical response.
Romans 5:20 is this statement exactly. "Where sin increased, grace abounded all the more" is not merely a comfort — it is the pharmacological description of the competitive antagonism rightward shift. Grace scales with sin because the dose of agonist required scales with antagonist concentration.
Separator Tests & Falsification
Primary: If grace effects showed no dose-response relationship — if spiritual growth were entirely binary (all-or-nothing with no gradation) OR entirely linear (no threshold, no saturation) — the Hill equation mapping would fail. Scripture describes gradual sanctification with threshold effects and ultimate limits, consistent with sigmoidal dose-response.
Secondary: If community showed no amplifying effect on individual faith-response — if gathering together produced identical outcomes to solitary practice at equivalent "dose" — the cooperativity interpretation (n > 1) would fail. Matthew 18:20 and Hebrews 10:25 both predict community amplification.
Tertiary: If competitive antagonism were not the correct pharmacological model for sin — if sin acted as a non-competitive antagonist (different binding site, reducing E_max rather than shifting EC50) — the mathematical form of the rightward-shift prediction would need to be revised, though the structural isomorphism would survive in modified form.
Ephesians 2:8-9 (grace through faith, not works) · Romans 5:20 (where sin increased, grace abounded) · Matthew 18:20 (community cooperativity) · Hebrews 10:14 (single offering, ephapax) · Ephesians 4:13 (E_max = measure of the fullness of Christ) · Romans 10:2 (zeal without knowledge = toxic dose) · Hebrews 12:11 (side effects: "painful rather than pleasant, but it yields the peaceful fruit of righteousness")